UK Novel foods application

1. The first part is a feasibility assessment to assess the readiness for an application. We review the CBD raw material from ‘seed-to-shelf’ and look at its supply chain. Does it meet Good Agricultural Practice (GAP)? Next, we audit the manufacturing and quality processes, and finished product specifications. By going through a detailed questionnaire, we can highlight any areas of potential weakness for improvement to ensure we have all the elements needed for a successful novel foods application.

2. The second part of the process, is the collation of the required data within the specific FSA framework, and the completion of  the application. As the data required for applications is very similar, with specific components relating to ex. CBD toxicology, there is a opportunity to share the high costs of putting together background data. Hence, not only can we guide clients through the complex regulatory process, we can help keep costs down by sharing some otherwise costly data.

Further information and guidance is available from food.gov.uk/business-guidance/regulated-products/novel-foods-guidance.

In January 2019, the status of CBD as a novel food was confirmed and added to the Novel Foods Catalogue by the Foods Standard Agency (FSA). CBD products may only be sold legally as a novel food, and food businesses must apply for authorisations of their CBD extracts and isolates.